| Late-onset Blueberry Muffin Lesions Following Recombinant Erythropoietin Administration in a Premature Infant. | |
| | |
MedLine Citation:
|
PMID: 23007340 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Recombinant erythropoietin is being used in premature population for anemia of prematurity. It is considered very safe in this population, although risks are still being evaluated. We report the first case of dermal erythropoiesis as a side effect of recombinant erythropoietin in an extremely prematurely born infant presenting with late-onset blueberry muffin lesions. |
| | |
Authors:
|
Vishal Pandey; Krishna Dummula; Garth Fraga; Prabhu Parimi |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of pediatric hematology/oncology Volume: 34 ISSN: 1536-3678 ISO Abbreviation: J. Pediatr. Hematol. Oncol. Publication Date: 2012 Oct |
Date Detail:
|
Created Date: 2012-09-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9505928 Medline TA: J Pediatr Hematol Oncol Country: United States |
Other Details:
|
Languages: eng Pagination: 534-5 Citation Subset: IM |
Affiliation:
|
Departments of *Pediatrics, Division of Neonatology ‡Pathology, University of Kansas, School of Medicine †Neonatal Intensive Care Unit §Department of Pathology and Laboratory Medicine, University of Kansas Hospital, Kansas City, KS. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Gemcitabine, docetaxel, and bevacizumab in relapsed and refractory pediatric sarcomas.
Next Document: Report of a young girl with MYH9 mutation and review of the literature.